Pharma Mar | PHM - Interest Expense On Debt


Pharma Mar reported EUR117K in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Akebia Therapeutics 362.52M 357.69M Mar/2026
Alaunos Therapeutics USD 1.07M 215K Jun/2023
Avita Medical AUD 1.25M 100K Jun/2025
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Ionis Pharmaceuticals USD 17M 1000K Mar/2026
IQVIA Holdings USD 192M 1000K Mar/2026
Laboratorios Farma EUR 699K 666.2K Jun/2025
Moderna USD 11.49B 36B Mar/2026
Organon & Co USD 111M 17M Mar/2026
Pharma Mar EUR 117K 1.24M Sep/2025
Revvity USD 24.72M 1.2M Mar/2026
Tectonic Therapeutic USD 246.58M 246.56M Mar/2026
Viatris USD 120.1M 500K Mar/2026
Xeris Pharmaceuticals USD 6.88M 269K Mar/2026